Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

Brentuximab vedotin combined with cyclophosphamide, doxorubicin, and prednisone (CHP) shows promising results as a first-line ...

The French biotech is developing a new drug approach in a disease market that’s projected to grow to $30 billion by 2030.

An experimental oral treatment from Abivax helped ease symptoms in patients with ulcerative colitis, a major win for the ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

TOKYO -- Roughly 2.5 million doses of oral COVID-19 medication bought by the Japanese government during the pandemic expired and were disposed of by the end of February, Nikkei has learned.